Using hyaluronic acid gel to prevent adhesions after surgery for retained pregnancy tissue

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of auto-cross linked hyaluronic acid gel in preventing the reformation of intrauterine adhesions following hysteroscopic resection of retained products of conception (RPOC). RPOC can lead to complications such as infertility and menstrual abnormalities if not treated properly. The study will randomly assign patients who have undergone the surgical procedure to receive either the gel or standard care, allowing for a comparison of outcomes related to adhesion formation. The goal is to determine if the gel can reduce the risk of complications associated with RPOC treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of retained products of conception
* Written consent obtained

Exclusion Criteria:

* Patients with severe complications of medicine and surgery
* Acute or chronic genital tract inflammation
* No understanding or approving the randomized controlled trial

Where it's running

• FuxingHospital，Captital Medical University
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Xue Yang, Master
• Email: yuanxy515@163.com
• Phone: 8618810957056

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Drug-assisted expectant care versus surgery for retained products of conception

  This project tests whether trying drug-assisted expectant management and waiting for the right time for surgery in people with retained products of conception reduces intrauterine scarring and better preserves fertility compared with immediate curettage.

  Recruiting The Third Xiangya Hospital of Central South University · Changsha, Hunan · NCT07421895

• Operative hysteroscopy in the operating room versus the outpatient clinic

  This will test whether operative hysteroscopy done in an outpatient clinic works as well as when it's done in the operating room for women treated for fibroids, polyps, or retained products of conception.

  Recruiting Centre Hospitalier Intercommunal Creteil · Créteil · NCT07146659

• Intracervical vasopressin to help hysteroscopic removal of retained pregnancy tissue.

  This test checks whether injecting vasopressin into the cervix during hysteroscopic removal helps women 18–51 have complete removal of retained pregnancy tissue.

  Recruiting Phase 4 Prisma Health-Upstate · Greenville, South Carolina · NCT07102615

• Evaluating conservative management for retained products of conception and enhanced myometrial vascularity

  This study is testing if gentle treatments for people with leftover pregnancy tissue after a miscarriage can help them recover naturally over two menstrual cycles.

  Recruiting Fu Xing Hospital, Capital Medical University · Beijing · NCT06862089

• Hysteroscopy for treating retained products of conception after miscarriage

  This study tests whether a procedure called hysteroscopy helps women who had a miscarriage and still have some pregnancy tissue to get pregnant again faster compared to just waiting it out.

  Recruiting University Hospital, Ghent · Ghent · NCT04804332

• Misoprostol versus watchful waiting for retained tissue after first-trimester medical abortion

  This project will test whether taking misoprostol or simply watching and waiting works better to clear retained tissue after a first‑trimester medical abortion in women aged 18–45 with ultrasound evidence of retained products.

  Recruiting Meir Medical Center · Kfar Saba · NCT07534982

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.